We report co-infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Mycoplasma pneumoniae in a patient with pneumonia in India. Atypical bacterial pathogens causing community-acquired pneumonia may share similar clinical presentations and radiographic features with SARS-CoV-2 making a thorough differential diagnosis essential. The co-infection of SARS-CoV-2 and M. pneumoniae is infrequently reported in the literature. Broader testing for common respiratory pathogens should be performed in severe COVID-19 cases to rule out other concurrent infections. Early identification of co-existing respiratory pathogens could provide pathogen-directed therapy, and can save patient lives during the ongoing COVID-19 outbreak.
【저자키워드】 COVID-19, therapy, Pneumonia, Infection, Co-infections, Mycoplasma pneumoniae, 【초록키워드】 SARS-CoV-2, coronavirus, severe COVID-19, India, infections, COVID-19 outbreak, Patient, Co-infection, differential diagnosis, community-acquired pneumonia, Mycoplasma pneumoniae, clinical presentation, acute respiratory syndrome, respiratory pathogen, Radiographic, pneumoniae, bacterial pathogen, feature, performed, reported, 【제목키워드】 Case report, Co-infection, Mycoplasma pneumoniae,